Friday, November 8, 2024
21 C
New York

Medlab Clinical: Recieves Australian patent for NanoCelle

  • Biotech company Medlab Clinical (MDC) has been granted an Australian patent for its NanoCelle delivery platform
  • Essentially, NanoCelle delivers drug formulations via an oral spray
  • So far, product testing results have indicated the spray can lead to better absorption of the drugs, helping the formulation avoid ingested routes
  • It can also potentially lower drug dosages and reduce the side effects of some formulations
  • Medlab has also filed patent applications in other jurisdictions, such as the U.S., Europe and New Zealand
  • On the market this afternoon, Medlab is up 3.03 per cent, trading for 17 cents per share

Hot this week

Banking as a Service: Meaning, Examples, Benefits and Future

The push for open banking has led to a...

What is Fintech?

Fintech: A term used to refer to innovations in...

Best fintech blogs and websites

Fintech (financial technology) has been an interesting part of...

How to buy shares online

Buying shares online in India has come a long...

Is it worth investing in life insurance over 60?

Is it worth investing in life insurance over 60? As...

FTC Challenges Neobank Dave Over Deceptive Marketing and Hidden Fees

The Federal Trade Commission (FTC) has filed a...

Bank of New Zealand Acquires BlinkPay to Boost Open Banking Solutions

Bank of New Zealand (BNZ) has acquired Auckland-based...

FE Fundinfo Acquires Matterhorn to Enhance AIFMD Reporting Services

FE Fundinfo has acquired Matterhorn Reporting Services to...

Konsentus Chosen to Drive Open Banking API Standards for Bank of Namibia

UK-based regtech Konsentus has been selected by the...

Monument Technology Appoints New CTO and CCO to Strengthen BPaaS Offerings

Monument Technology, a UK-based provider of Banking-Platform-as-a-Service (BPaaS)...

Related Articles

Popular Categories

spot_imgspot_img